Search research articles
Contact Us
Filters
Showing results (241-250 of 303) with videos related to
Page
of 31
Sort By:
Cancer Research and Treatment
|
January 6, 2017
Genetic Alterations and Their Clinical Implications in High-Recurrence Risk Papillary Thyroid Cancer
Min-Young Lee, Bo Mi Ku, Hae Su Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 12, 2019
Osimertinib for Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09)
Jang Ho Cho, Sung Hee Lim, Ho Jung An, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 26, 2013
Clinical applicability of staging small cell lung cancer according to the seventh edition of the TNM staging system
Byung Woo Jhun, Kyung-Jong Lee, Kyeongman Jeon, et al.
Cancer
|
October 16, 2023
Biomarker-driven phase 2 umbrella trial: Clinical efficacy of olaparib monotherapy and combination with ceralasertib (AZD6738) in small cell lung cancer
Sehhoon Park, Yu Jung Kim, Young Joo Min, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 7, 2025
Phase II study of lazertinib and pemetrexed in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer with leptomeningeal metastases: the KCSG LU 21-01, LAZARUS study
Hyun Ae Jung, Tae Min Kim, Hye Ryun Kim, et al.
Genomics
|
February 26, 2013
Multiplexed deep sequencing analysis of ALK kinase domain identifies resistance mutations in relapsed patients following crizotinib treatment
Donghui Huang, Dong-Wan Kim, Athanasios Kotsakis, et al.
Anticancer Research
|
November 14, 2013
High-throughput molecular genotyping for small biopsy samples in advanced non-small cell lung cancer patients
Chi Hoon Maeng, Ho Yun Lee, Young Wook Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 16, 2015
A Phase Ib/II Study of Afatinib in Combination with Nimotuzumab in Non-Small Cell Lung Cancer Patients with Acquired Resistance to Gefitinib or Erlotinib
Ji Yun Lee, Jong-Mu Sun, Sung Hee Lim, et al.
Cancer
|
June 26, 2020
Biomarker-driven phase 2 umbrella trial study for patients with recurrent small cell lung cancer failing platinum-based chemotherapy
Sehhoon Park, Joonho Shim, Peter G S Mortimer, et al.
European Journal of Immunology
|
June 9, 2020
MDSC subtypes and CD39 expression on CD8<sup>+</sup> T cells predict the efficacy of anti-PD-1 immunotherapy in patients with advanced NSCLC
Jiae Koh, Youjin Kim, Kyoung Young Lee, et al.
Page
of 31
Search research articles
Search
Showing results (241-250 of 303) with videos related to
Sort By:
Page
of 31
Cancer Research and Treatment
|
January 6, 2017
Genetic Alterations and Their Clinical Implications in High-Recurrence Risk Papillary Thyroid Cancer
Min-Young Lee, Bo Mi Ku, Hae Su Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 12, 2019
Osimertinib for Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09)
Jang Ho Cho, Sung Hee Lim, Ho Jung An, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 26, 2013
Clinical applicability of staging small cell lung cancer according to the seventh edition of the TNM staging system
Byung Woo Jhun, Kyung-Jong Lee, Kyeongman Jeon, et al.
Cancer
|
October 16, 2023
Biomarker-driven phase 2 umbrella trial: Clinical efficacy of olaparib monotherapy and combination with ceralasertib (AZD6738) in small cell lung cancer
Sehhoon Park, Yu Jung Kim, Young Joo Min, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 7, 2025
Phase II study of lazertinib and pemetrexed in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer with leptomeningeal metastases: the KCSG LU 21-01, LAZARUS study
Hyun Ae Jung, Tae Min Kim, Hye Ryun Kim, et al.
Genomics
|
February 26, 2013
Multiplexed deep sequencing analysis of ALK kinase domain identifies resistance mutations in relapsed patients following crizotinib treatment
Donghui Huang, Dong-Wan Kim, Athanasios Kotsakis, et al.
Anticancer Research
|
November 14, 2013
High-throughput molecular genotyping for small biopsy samples in advanced non-small cell lung cancer patients
Chi Hoon Maeng, Ho Yun Lee, Young Wook Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 16, 2015
A Phase Ib/II Study of Afatinib in Combination with Nimotuzumab in Non-Small Cell Lung Cancer Patients with Acquired Resistance to Gefitinib or Erlotinib
Ji Yun Lee, Jong-Mu Sun, Sung Hee Lim, et al.
Cancer
|
June 26, 2020
Biomarker-driven phase 2 umbrella trial study for patients with recurrent small cell lung cancer failing platinum-based chemotherapy
Sehhoon Park, Joonho Shim, Peter G S Mortimer, et al.
European Journal of Immunology
|
June 9, 2020
MDSC subtypes and CD39 expression on CD8<sup>+</sup> T cells predict the efficacy of anti-PD-1 immunotherapy in patients with advanced NSCLC
Jiae Koh, Youjin Kim, Kyoung Young Lee, et al.
Page
of 31